VERA
Vera Therapeutics, Inc.
Price Chart
No historical data available
Latest Quote
$34.23
+0.15 (+0.44%)
Current Price
| Previous Close | $34.08 |
| Open | $33.73 |
| Day High | $34.40 |
| Day Low | $33.65 |
| Volume | 2,996,884 |
Stock Information
| Shares Outstanding | 72.06M |
| Total Debt | $76.91M |
| Cash Equivalents | $499.16M |
| Net Income | $-401.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $2.47B |
| EPS (TTM) | $-5.87 |
| Exchange | NGM |
Recent Price History
No history data available. Data will be fetched automatically.
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on VERA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $7,531,000 | $7,626,000 | $3,786,000 | $992,000 |
| Total Expenses | $315,473,000 | $167,170,000 | $102,012,000 | $90,903,000 |
| Other Income Expense | $-1,089,000 | $1,935,000 | $1,830,000 | $1,090,000 |
| Other Non Operating Income Expenses | $-1,089,000 | $1,935,000 | $1,830,000 | $1,899,000 |
| Net Non Operating Interest Income Expense | $16,948,000 | $13,088,000 | $4,193,000 | $758,000 |
| Interest Expense Non Operating | $7,531,000 | $7,626,000 | $3,786,000 | $992,000 |
| Operating Expense | $315,473,000 | $167,170,000 | $102,012,000 | $90,903,000 |
| General And Administrative Expense | $100,217,000 | $40,998,000 | $23,787,000 | $21,910,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Net Interest Income | $16,948,000 | $13,088,000 | $4,193,000 | $758,000 |
| Interest Income | $24,479,000 | $20,714,000 | $7,979,000 | $1,750,000 |
| Normalized Income | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-88,416,890 |
| Net Income From Continuing And Discontinued Operation | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Total Operating Income As Reported | $-315,473,000 | $-167,170,000 | $-102,012,000 | $-90,903,000 |
| Net Income Common Stockholders | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Net Income | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Net Income Including Noncontrolling Interests | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Net Income Continuous Operations | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Pretax Income | $-299,614,000 | $-152,147,000 | $-95,989,000 | $-89,055,000 |
| Interest Income Non Operating | $24,479,000 | $20,714,000 | $7,979,000 | $1,750,000 |
| Operating Income | $-315,473,000 | $-167,170,000 | $-102,012,000 | $-90,903,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-4.66 | $-2.75 | $-2.25 | $-3.35 |
| Basic EPS | $-4.66 | $-2.75 | $-2.25 | $-3.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-169,890 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-291,615,000 | $-144,416,000 | $-92,182,000 | $-87,254,000 |
| Reconciled Depreciation | $468,000 | $105,000 | $21,000 | $-846,000 |
| EBITDA (Bullshit earnings) | $-291,615,000 | $-144,416,000 | $-92,182,000 | $-88,063,000 |
| EBIT | $-292,083,000 | $-144,521,000 | $-92,203,000 | $-88,063,000 |
| Diluted Average Shares | $64,233,814 | $55,326,680 | $42,707,072 | $26,570,676 |
| Basic Average Shares | $64,233,814 | $55,326,680 | $42,707,072 | $26,570,676 |
| Diluted NI Availto Com Stockholders | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Tax Provision | $1,000 | $1,000 | $1,000 | $1,000 |
| Research And Development | $215,256,000 | $126,172,000 | $78,225,000 | $68,993,000 |
| Selling General And Administration | $100,217,000 | $40,998,000 | $23,787,000 | $21,910,000 |
| Other Gand A | $100,217,000 | $40,998,000 | $23,787,000 | $21,910,000 |
| Total Unusual Items | - | - | $-47,000 | $-809,000 |
| Total Unusual Items Excluding Goodwill | - | - | $-47,000 | $-809,000 |
| Gain On Sale Of Security | - | - | $-47,000 | $-809,000 |
| Gain On Sale Of Business | - | - | - | $0 |
| Restructuring And Mergern Acquisition | - | - | - | - |
Fetched: 2026-09-01
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $604,521,000 | $577,155,000 | $101,685,000 | $76,908,000 |
| Total Assets | $734,733,000 | $655,681,000 | $175,546,000 | $131,435,000 |
| Total Non Current Assets | $5,850,000 | $4,463,000 | $3,523,000 | $5,737,000 |
| Other Non Current Assets | $2,553,000 | $131,000 | $482,000 | $513,000 |
| Current Assets | $728,883,000 | $651,218,000 | $172,023,000 | $125,698,000 |
| Other Current Assets | $2,535,000 | $1,383,000 | $2,237,000 | $719,000 |
| Prepaid Assets | $8,474,000 | $5,210,000 | $8,558,000 | $10,326,000 |
| Receivables | $3,285,000 | $3,773,000 | $512,000 | - |
| Accrued Interest Receivable | $3,285,000 | $3,773,000 | $512,000 | - |
| Cash Cash Equivalents And Short Term Investments | $714,589,000 | $640,852,000 | $160,716,000 | $114,653,000 |
| Cash And Cash Equivalents | $354,725,000 | $92,646,000 | $45,681,000 | $43,459,000 |
| Cash Equivalents | $350,106,000 | $89,727,000 | - | - |
| Cash Financial | $4,619,000 | $2,919,000 | - | - |
| Investmentin Financial Assets | - | - | - | $58,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $77,306,000 | $54,638,000 | $53,708,000 | $31,286,000 |
| Long Term Debt And Capital Lease Obligation | $76,757,000 | $53,155,000 | $51,272,000 | $28,641,000 |
| Long Term Debt | $74,838,000 | $50,687,000 | $49,877,000 | $24,810,000 |
| Current Debt And Capital Lease Obligation | $549,000 | $1,483,000 | $2,436,000 | $2,645,000 |
| Net Debt | - | - | $4,196,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $130,212,000 | $78,526,000 | $73,861,000 | $54,527,000 |
| Total Non Current Liabilities Net Minority Interest | $76,757,000 | $53,155,000 | $51,558,000 | $28,927,000 |
| Current Liabilities | $53,455,000 | $25,371,000 | $22,303,000 | $25,600,000 |
| Other Current Liabilities | $1,367,000 | $1,753,000 | - | - |
| Payables And Accrued Expenses | $51,539,000 | $22,135,000 | $19,867,000 | $22,955,000 |
| Payables | $21,901,000 | $7,882,000 | $13,044,000 | $14,771,000 |
| Accounts Payable | $21,898,000 | $7,665,000 | $11,118,000 | $11,991,000 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $604,521,000 | $577,155,000 | $101,685,000 | $76,908,000 |
| Total Equity Gross Minority Interest | $604,521,000 | $577,155,000 | $101,685,000 | $76,908,000 |
| Stockholders Equity | $604,521,000 | $577,155,000 | $101,685,000 | $76,908,000 |
| Gains Losses Not Affecting Retained Earnings | $786,000 | $393,000 | $251,000 | $-224,000 |
| Other Equity Adjustments | $786,000 | $393,000 | $251,000 | $-224,000 |
| Retained Earnings | $-760,865,000 | $-461,250,000 | $-309,102,000 | $-213,112,000 |
| Other | ||||
| Ordinary Shares Number | $71,267,429 | $63,559,858 | $44,452,161 | $27,800,861 |
| Share Issued | $71,267,429 | $63,559,858 | $44,452,161 | $27,800,861 |
| Tangible Book Value | $604,521,000 | $577,155,000 | $101,685,000 | $76,908,000 |
| Invested Capital | $679,359,000 | $627,842,000 | $151,562,000 | $101,718,000 |
| Working Capital | $675,428,000 | $625,847,000 | $149,720,000 | $100,098,000 |
| Capital Lease Obligations | $2,468,000 | $3,951,000 | $3,831,000 | $6,476,000 |
| Total Capitalization | $679,359,000 | $627,842,000 | $151,562,000 | $101,718,000 |
| Additional Paid In Capital | $1,364,529,000 | $1,037,948,000 | $410,492,000 | $290,216,000 |
| Capital Stock | $71,000 | $64,000 | $44,000 | $28,000 |
| Common Stock | $71,000 | $64,000 | $44,000 | $28,000 |
| Long Term Capital Lease Obligation | $1,919,000 | $2,468,000 | $1,395,000 | $3,831,000 |
| Current Capital Lease Obligation | $549,000 | $1,483,000 | $2,436,000 | $2,645,000 |
| Current Accrued Expenses | $29,638,000 | $14,253,000 | $6,823,000 | $8,184,000 |
| Dueto Related Parties Current | $3,000 | $217,000 | $1,926,000 | $2,780,000 |
| Net PPE | $3,297,000 | $4,332,000 | $3,041,000 | $5,224,000 |
| Gross PPE | $3,297,000 | $4,332,000 | $3,041,000 | $5,224,000 |
| Other Properties | $1,374,000 | $960,000 | $92,000 | $51,000 |
| Buildings And Improvements | $1,923,000 | $3,372,000 | $2,949,000 | $5,173,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $359,864,000 | $548,206,000 | $115,035,000 | $71,194,000 |
| Preferred Stock | - | $0 | $0 | $0 |
| Non Current Accrued Expenses | - | $0 | $286,000 | $286,000 |
| Investments And Advances | - | - | - | $58,000 |
| Available For Sale Securities | - | - | - | $58,000 |
Fetched: 2026-09-01
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-241,734,000 | $-135,651,000 | $-92,244,000 | $-67,658,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-241,104,000 | $-134,679,000 | $-92,181,000 | $-67,596,000 |
| Cash Flow From Continuing Operating Activities | $-241,104,000 | $-134,679,000 | $-92,181,000 | $-67,596,000 |
| Operating Gains Losses | - | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-630,000 | $-972,000 | $-63,000 | $-62,000 |
| Investing Cash Flow | $194,286,000 | $-425,029,000 | $-39,431,000 | $-70,552,000 |
| Cash Flow From Continuing Investing Activities | $194,286,000 | $-425,029,000 | $-39,431,000 | $-70,552,000 |
| Net Other Investing Changes | $-800,000 | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-13,000 | $0 | - |
| Issuance Of Capital Stock | $300,500,000 | $632,537,000 | $115,000,000 | $86,131,000 |
| Financing Cash Flow | $308,897,000 | $606,673,000 | $133,541,000 | $101,933,000 |
| Cash Flow From Continuing Financing Activities | $308,897,000 | $606,673,000 | $133,541,000 | $101,933,000 |
| Net Other Financing Charges | $-21,922,000 | $-39,264,000 | $-7,256,000 | $-6,097,000 |
| Net Common Stock Issuance | $300,500,000 | $632,524,000 | $115,000,000 | $86,131,000 |
| Common Stock Issuance | $300,500,000 | $632,537,000 | $115,000,000 | $86,131,000 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Issuance Of Debt | $23,338,000 | $0 | $24,741,000 | $19,816,000 |
| Interest Paid Supplemental Data | $6,720,000 | $6,652,000 | $3,352,000 | $895,000 |
| End Cash Position | $354,725,000 | $92,646,000 | $45,681,000 | $43,752,000 |
| Beginning Cash Position | $92,646,000 | $45,681,000 | $43,752,000 | $79,967,000 |
| Changes In Cash | $262,079,000 | $46,965,000 | $1,929,000 | $-36,215,000 |
| Proceeds From Stock Option Exercised | $6,981,000 | $13,413,000 | $1,056,000 | $2,083,000 |
| Common Stock Payments | $0 | $-13,000 | $0 | - |
| Net Issuance Payments Of Debt | $23,338,000 | $0 | $24,741,000 | $19,816,000 |
| Net Long Term Debt Issuance | $23,338,000 | $0 | $24,741,000 | $19,816,000 |
| Long Term Debt Issuance | $23,338,000 | $0 | $24,741,000 | $19,816,000 |
| Net Investment Purchase And Sale | $195,716,000 | $-424,057,000 | $-39,368,000 | $-70,490,000 |
| Sale Of Investment | $506,162,000 | $278,958,000 | $185,562,000 | $78,000,000 |
| Purchase Of Investment | $-310,446,000 | $-703,015,000 | $-224,930,000 | $-148,490,000 |
| Net PPE Purchase And Sale | $-630,000 | $-972,000 | $-63,000 | $-62,000 |
| Purchase Of PPE | $-630,000 | $-972,000 | $-63,000 | $-62,000 |
| Change In Working Capital | $22,992,000 | $2,660,000 | $-5,822,000 | $6,747,000 |
| Change In Other Current Liabilities | $-1,483,000 | $-2,407,000 | $-2,645,000 | $-2,602,000 |
| Change In Other Current Assets | $51,000 | $351,000 | $-262,000 | $-111,000 |
| Change In Payables And Accrued Expense | $28,352,000 | $3,735,000 | $-3,088,000 | $17,642,000 |
| Change In Accrued Expense | $14,442,000 | $7,188,000 | $-2,215,000 | $7,036,000 |
| Change In Payable | $13,910,000 | $-3,453,000 | $-873,000 | $10,606,000 |
| Change In Account Payable | $13,910,000 | $-3,453,000 | $-873,000 | $10,606,000 |
| Change In Prepaid Assets | $-3,928,000 | $981,000 | $173,000 | $-8,182,000 |
| Other Non Cash Items | $4,106,000 | $2,874,000 | $2,550,000 | $5,863,000 |
| Stock Based Compensation | $37,926,000 | $20,802,000 | $11,493,000 | $8,887,000 |
| Amortization Of Securities | $-6,981,000 | $-8,972,000 | $-4,433,000 | - |
| Depreciation Amortization Depletion | $468,000 | $105,000 | $21,000 | $-846,000 |
| Depreciation And Amortization | $468,000 | $105,000 | $21,000 | $-846,000 |
| Net Income From Continuing Operations | $-299,615,000 | $-152,148,000 | $-95,990,000 | $-89,056,000 |
| Unrealized Gain Loss On Investment Securities | - | - | $47,000 | $809,000 |
| Depreciation | - | - | $-4,086,000 | $-846,000 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Sale Of Intangibles | - | - | - | $0 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
| Repayment Of Debt | - | - | - | - |
| Long Term Debt Payments | - | - | - | - |
| Sale Of PPE | - | - | - | - |
| Asset Impairment Charge | - | - | - | - |
Fetched: 2026-09-01